Latham & Watkins LLP represented Terns Pharmaceuticals in the offering and Davis Polk advised the underwriters involved. Terns Pharmaceuticals, Inc. (Nasdaq: TERN), a clinical-stage biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented UNITY Biotechnology in the transaction. UNITY Biotechnology, Inc. (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, has...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...
You must be a Standard 1 Year member to access this content.
Goodwin advised Morgan Stanley on the deal, while Latham & Watkins represented Amplitude. Amplitude, Inc., a pioneer in digital optimization, announced that, as of September 22, 2021,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Synaptics Incorporated on the deal while Morrison & Foerster represented DSP Group, Inc. Synaptics Incorporated (Nasdaq: SYNA) and DSP Group, Inc. (Nasdaq: DSPG)...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Doximity on the deal. Doximity (NYSE: DOCS) announced its initial public offering of 23,300,000 shares of its Class A common stock at a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal while Goodwin Procter LLP represented Marqeta, Inc. Marqeta announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. Rapid7, Inc. (Nasdaq: RPD) announced the Rule 144A offering of $525 million principal amount of its 0.25% Convertible...
You must be a Standard 1 Year member to access this content.
